About Medlinker
Medlinker is a Healthcare company based in Chengdu (China) founded in 2014 by Wang Shirui. Social networking for healthcare professionals is facilitated by Medlinker. It operates on a On-Demand Services, AI-as-a-Service, and HealthTech model. Medlinker has raised $841.52 million across 6 funding rounds from investors including Tencent, China Renaissance Group and Sino Biopharmaceutical. The company has 197 employees. Medlinker was last valued at $25 billion in December 2021. Its chief executive, as recorded, is Wang Shirui. Its website medlinker.com draws about 12 thousand monthly visits. Medlinker offers products and services including Future Doctor App and MedGPT. Its focus areas include Digital Health and Telemedicine. Its legal entity is Chengdu MedCloud Technology Co., Ltd.
Company details
A digital health platform is operated by Medlinker, connecting patients with renowned doctors from top hospitals in China for free online consultations. Services are offered across 26 clinical disciplines and over 100 subspecialties, covering more than 30,000 diseases. AI tools like MedGPT are utilized to assist doctors in diagnostics, while ensuring all advice is reviewed by real clinicians. The platform is focused on making premium medical resources accessible, promoting rational medical practices, and avoiding over-treatment. Solutions are tailored for common ailments and select specialized conditions, supported by extensive medical data and clinical guidelines.
- Headquarters Chengdu, China
- Employees 197
- Founders Wang Shirui
- Stage Unicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website medlinker.com/index
- Social LinkedIn
- Legal Name Chengdu Medcloud Technology Co., Ltd.
- Total Equity Funding$841.52M (USD)
in 6 rounds
- Latest Funding Round$514M (USD), Series E
Dec 2021
- InvestorsTencent
& 11 more
- Employee Count197
Products & Services of Medlinker
Medlinker offers a comprehensive portfolio of products and services, including Future Doctor App and MedGPT.
Online consultation platform connecting patients with expert doctors.
AI tool assisting doctors with diagnostic efficiency.
Funding Insights of Medlinker
Medlinker has successfully raised a total of $841.52M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $514 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $841.52M
- Total Rounds 6
- Last Round Series E β $514M
- Investors Count 12
All 6 funding rounds of Medlinker with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $514M | Series E | $25B | β | |
| Nov 2020 | $76M | Series D | β | β | β |
| Jun 2018 | $151.07M | Series D | β | β | |
| Dec 2017 | $60.45M | Series C | β | China Electronic Corporation | |
| Sep 2015 | $40M | Series B | β | Tencent, Yunfeng Capital | β |
| Jun 2015 | Series A | β | β |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2021 | $25B | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Medlinker
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $25B (Dec 2021). 12 investors in total: 12 institutional.
Investors in Medlinker
Medlinker has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, China Renaissance Group and Sino Biopharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
M&A advisory, asset management firm, and private equity fund focused on multiple sectors | 2005 | huaxing.com | Chaoyang, China | |
Private equity investments are managed by Yunfeng Capital in China. | yfc.cn | Shanghai, China | ||
Early-stage tech investments in China are managed by Ceyuan Ventures. | ceyuan.com | Hong Kong, China | ||
Private equity investments in mergers and acquisitions are managed. | sensegaincapital.com | Beijing, China | ||
PreAngel is engaged in angel investment for early-stage startups. | pre-angel.com | |||
Investments are made in AI, fintech, semiconductor, and energy companies. | hermitagecap.com | Hong Kong, China | ||
Investments in early-stage tech startups are made by PreAngel Fund. | preangelfund.com | Sunnyvale, United States | ||
| luminousvc.com | ||||
Generics for cardio-cerebral diseases and hepatitis are developed and manufactured. | 2000 | sinobiopharm.com | Hong Kong, China | |
HongShan is engaged in venture capital investments for innovative companies. | hongshan.com | Hong Kong, China |
Investor details for Medlinker
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medlinker
1 people are tracked at Medlinker (1 in leadership); the tracked headcount is 197.
| Name | Role | Group |
|---|---|---|
Wang Shirui | Founder & CEO | Leadership |
Complete people profiles for Medlinker
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Medlinker
5 dated milestones of Medlinker across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Medlinker is founded.
- Funding First funding round.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series E, of $514.0M.
- Milestone Reaches Decacorn status.
Web traffic of Medlinker
The website of Medlinker (medlinker.com) receives about 12.5K visits a month.
- Monthly visits12.5K
▲ 26.7% vs previous month
Websites whose visitors overlap most with Medlinker. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 91160.com | 100% | 150.5K | #142,695 | View details | |
miaoshou.net | miaoshou.net | 100% | #127,697 | β | |
zsszyy.com | zsszyy.com | 100% | #2,193,683 | β | |
sdent.com.cn | sdent.com.cn | 74% | #390,701 | β | |
yxppt.com | yxppt.com | 72% | #2,104,530 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 12 similar websites and full traffic analytics for Medlinker
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medlinker
Complete news archive for Medlinker
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medlinker
Medlinker was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Medlinker is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
Wang Shirui is the CEO of Medlinker, as recorded in our data. They have also founded this company.
Medlinker is a funded company, having raised a total of $841.52M across 6 funding rounds to date.
Medlinker has 197 employees.
A digital health platform is operated by Medlinker, connecting patients with renowned doctors from top hospitals in China for free online consultations. Services are offered across 26 clinical disciplines and over 100 subspecialties, covering more than 30,000 diseases. AI tools like MedGPT are utilized to assist doctors in diagnostics, while ensuring all advice is reviewed by real clinicians. The platform is focused on making premium medical resources accessible, promoting rational medical practices, and avoiding over-treatment. Solutions are tailored for common ailments and select specialized conditions, supported by extensive medical data and clinical guidelines.
Medlinker offers Future Doctor App and MedGPT.
Medlinker has 12 investors. Key investors include Tencent, China Renaissance Group, Sino Biopharmaceutical, HongShan, and China Electronic Corporation.
The valuation of Medlinker is $25B as of Dec 2021.
Medlinker operates through Chengdu Medcloud Technology Co., Ltd..